KRM Ayurveda IPO...
15 Jan, 2026
Gaudium IVF & Women Health IPO
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Gaudium IVF & Women Health IPO GMP
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Gaudium IVF & Women Health IPO Details
| Detail | Description |
|---|---|
| IPO Date | - |
| Listing Date | - |
| Face Value | ₹5.00 per Equity Share |
| Issue Price Band | - |
| Lot Size | - |
| Sale Type | - |
| Total Issue Size | Up to 2,08,86,200 Equity Shares |
| Reserved for Market Maker | - |
| Fresh Issue(Ex Market Maker) | Up to 1,13,92,500 Equity Shares |
| Offer for Sale | Up to 94,93,700 Equity Shares (by Dr. Manika Khanna) |
| Net Offered to Public | - |
| Issue Type | 100% Book Building Offer |
| Listing At | BSE and NSE |
| Share Holding Pre Issue | 6,13,85,084 Equity Shares |
| Share Holding Post Issue | 7,27,51,760 Equity Shares |
Gaudium IVF & Women Health IPO Timeline
| Detail | Description |
|---|---|
| IPO Open Date | - |
| IPO Close Date | - |
| Tentative Allotment | - |
| Initiation of Refunds | - |
| Credit of Shares to Demat | - |
| Tentative Listing Date | - |
| Cut-off time for UPI mandate confirmation | 5:00 PM on the Bid/Offer Closing Date |
Gaudium IVF & Women Health IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 1 | - | ₹14,000 - ₹15,000 |
| Individual investors (Retail) (Max) | 13-14 | - | Up to ₹2,00,000 |
| S-HNI (Min) | 14-15 | - | Over ₹2,00,000 |
| S-HNI (Max) | 66-70 | - | Up to ₹10,00,000 |
| B-HNI (Min) | 71+ | - | Over ₹10,00,000 |
Gaudium IVF & Women Health IPO Promoter Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| Promoter Holding Pre Issue | ~99.98% |
| Promoter Holding Post Issue | 71.30% |
Competitive Strength:
- • Pan-India hub-and-spoke fertility clinic network with growing footprint.
- • Comprehensive advanced reproductive treatments including IVF, ICSI and IUI services.
- • Strong revenue and profit growth trend in recent fiscal periods.
Gaudium IVF & Women Health IPO Financial Information
| Period Ended | Assets | Total Income | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar 2025 | 88.51 | 70.96 | 19.13 | 46.30 | 15.60 | 18.93 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2024 | 51.01 | 48.15 | 10.32 | 26.99 | 26.00 | 15.72 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2023 | 36.63 | 44.26 | 13.53 | 22.73 | 21.74 | 9.78 | ||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 41.31% |
| ROCE | 39.70% |
| Debt/Equity | 0.41 |
| RoNW | 41.71% |
| PAT Margin | 26.96% |
| EBITDA Margin | 40.48% |
| Price to Book Value | - |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 3.12 | [.] |
| P/E (x) | [.] | [.] |
IPO DRHP Status
| # | Description | Date | File |
|---|---|---|---|
| 1 | Filed with SEBI/Exchange | 29-09-2025 | View DRHP |
| 2 | SEBI/Exchange approval received | - | - |
Read more :
.jpg)
